planning committee

Overcoming Barriers to Immune Therapy in Melanoma

Learning Objectives

At the conclusion of this course the participant was able to:

Identify the current FDA approved treatments for malignant melanomas;
List the state-of-the-art in immune-based treatments for malignant melanomas;
Discuss the advantages and potential toxicities of immune-based treatments for malignant melanomas;
Review the cellular pathways involved in immunity and autoimmunity in the context of melanoma therapy.

home

about us

calendar

conferences

online courses

site map

legal

privacy

BioSymposia, Inc. is accredited by the Accreditation Council for Continuing Medical Education, the American Nurses Association's American Nurses Credentialing Center, and the Accreditation Council for Pharmacy Education. We also work with other key accreditors.

This site contains medical information and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.